메뉴 건너뛰기




Volumn 376, Issue 9734, 2010, Pages 20-21

Clinical trials should begin and end with systematic reviews of relevant evidence: 12 years and waiting

Author keywords

[No Author keywords available]

Indexed keywords

CLINICAL TRIAL; COCHRANE LIBRARY; HEALTH CARE; LETTER; MEDICAL DECISION MAKING; MEDICAL LITERATURE; METHODOLOGY; PRIORITY JOURNAL; SYSTEMATIC REVIEW; BIBLIOMETRICS; LITERATURE; PUBLISHING; STANDARD;

EID: 77954750707     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)61045-8     Document Type: Letter
Times cited : (133)

References (11)
  • 1
    • 15744399418 scopus 로고    scopus 로고
    • Doing new research? Don't forget the old. Nobody should do a trial without reviewing what is known
    • Clarke M. Doing new research? Don't forget the old. Nobody should do a trial without reviewing what is known. PLoS Med 2004; 1: 100-02.
    • (2004) PLoS Med , vol.1 , pp. 100-102
    • Clarke, M.1
  • 2
    • 0033528213 scopus 로고    scopus 로고
    • How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing
    • Chalmers I, Altman DG. How can medical journals help prevent poor medical research? Some opportunities presented by electronic publishing. Lancet 1999; 353: 490-93.
    • (1999) Lancet , vol.353 , pp. 490-493
    • Chalmers, I.1    Altman, D.G.2
  • 3
    • 0032527534 scopus 로고    scopus 로고
    • Discussion sections in reports of controlled trials published in general medical journals: Islands in search of continents?
    • Clarke M, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals: islands in search of continents? JAMA 1998; 280: 280-82.
    • (1998) JAMA , vol.280 , pp. 280-282
    • Clarke, M.1    Chalmers, I.2
  • 4
    • 0037024302 scopus 로고    scopus 로고
    • Discussion sections in reports of controlled trials published in general medical journals
    • Clarke M, Alderson P, Chalmers I. Discussion sections in reports of controlled trials published in general medical journals. JAMA 2002; 287: 2799-801.
    • (2002) JAMA , vol.287 , pp. 2799-2801
    • Clarke, M.1    Alderson, P.2    Chalmers, I.3
  • 5
    • 34247860590 scopus 로고    scopus 로고
    • Reports of clinical trials should begin and end with up-todate systematic reviews of other relevant evidence: A status report
    • Clarke M, Hopewell S, Chalmers I. Reports of clinical trials should begin and end with up-todate systematic reviews of other relevant evidence: a status report. J R Soc Med 2007; 100: 187-90.
    • (2007) J R Soc Med , vol.100 , pp. 187-190
    • Clarke, M.1    Hopewell, S.2    Chalmers, I.3
  • 6
    • 67650047651 scopus 로고    scopus 로고
    • Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: Randomized, investigator blinded, controlled trial
    • Ndekha MJ, van Oosterhout JJG, Zijlstra EE, Manary M, Saloojee H, Manary MJ. Supplementary feeding with either ready-to-use fortified spread or corn-soy blend in wasted adults starting antiretroviral therapy in Malawi: randomized, investigator blinded, controlled trial. BMJ 2009; 338: b1867.
    • (2009) BMJ , vol.338
    • Ndekha, M.J.1    Van Oosterhout, J.J.G.2    Zijlstra, E.E.3    Manary, M.4    Saloojee, H.5    Manary, M.J.6
  • 8
    • 66149192533 scopus 로고    scopus 로고
    • Splint for base-of-thumb osteoarthritis: A randomized trial
    • Rannou F, Dimet J, Boutron I, et al. Splint for base-of-thumb osteoarthritis: a randomized trial. Ann Intern Med 2009; 150: 661-69.
    • (2009) Ann Intern Med , vol.150 , pp. 661-669
    • Rannou, F.1    Dimet, J.2    Boutron, I.3
  • 9
    • 65549146500 scopus 로고    scopus 로고
    • Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): An open-label, phase III, randomised controlled trial
    • for the TACT Trial Management Group and the TACT Trialists
    • Ellis P, Barrett-Lee P, Johnson L, et al, for the TACT Trial Management Group and the TACT Trialists. Sequential docetaxel as adjuvant chemotherapy for early breast cancer (TACT): an open-label, phase III, randomised controlled trial. Lancet 2009; 373: 1681-92.
    • (2009) Lancet , vol.373 , pp. 1681-1692
    • Ellis, P.1    Barrett-Lee, P.2    Johnson, L.3
  • 10
    • 9444255722 scopus 로고    scopus 로고
    • Improving the quality of reporting of randomized controlled trials: The CONSORT statement
    • Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials: the CONSORT statement. JAMA 1996; 276: 637-39.
    • (1996) JAMA , vol.276 , pp. 637-639
    • Begg, C.1    Cho, M.2    Eastwood, S.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.